$沛嘉医疗-B(09_老虎社区_美港股上老虎 - 老虎社区

1
评论
收藏

丁有鱼
10-31 10:23

$沛嘉医疗-B(09996)$ 沛嘉医疗拥有大中华区权益的JenaValve Trilogy心脏瓣膜系统ALIGN-AR试验的两年结果发布。ALIGN-AR 2 Years正向结果进一步证实了Trilogy心脏瓣膜系统对治疗严重、有症状的主动脉瓣关闭不全（AR）且高外科风险的患者具有安全性和持续有效性。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

1

举报

评论

推荐
最新

empty

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

老虎社区侵权投诉指引

中国互联网举报中心·北京互联网举报中心

网络谣言曝光台·扫黄打非举报中心

网络110报警服务

© 2018-2024 老虎社区版权所有

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

qrcode

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":365940418564200,"tweetId":"365940418564200","gmtCreate":1730341436392,"gmtModify":1730341438798,"author":{"id":3542437996277612,"idStr":"3542437996277612","authorId":3542437996277612,"authorIdStr":"3542437996277612","name":"丁有鱼","avatar":"https://static.tigerbbs.com/9d1a2a96b3ad87d1ec14e26d15d24e5d","vip":2,"userType":2,"introduction":"专注分析上市公司","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"社区优质创作者：发表过3篇及以上精华帖，且30天内发表过至少一篇精华帖并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.11","individualDisplayEnabled":0},"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"社区优质创作者：发表过3篇及以上精华帖，且30天内发表过至少一篇精华帖并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.01","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":21494,"starInvestorFlag":false},"themes":[],"images":[{"img":"https://static.tigerbbs.com/a0677190bc27cbb2be757ac2a9e9c41d","width":"1493","height":"1875"}],"coverImages":[{"img":"https://static.tigerbbs.com/a0677190bc27cbb2be757ac2a9e9c41d","width":"1493","height":"1875"}],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a> 沛嘉医疗拥有大中华区权益的JenaValve Trilogy心脏瓣膜系统ALIGN-AR试验的两年结果发布。ALIGN-AR 2 Years正向结果进一步证实了Trilogy心脏瓣膜系统对治疗严重、有症状的主动脉瓣关闭不全（AR）且高外科风险的患者具有安全性和持续有效性。</p><img src=\"https://static.tigerbbs.com/a0677190bc27cbb2be757ac2a9e9c41d\" tg-width=\"1493\" tg-height=\"1875\"></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/09996\">$沛嘉医疗-B(09996)$</a> 沛嘉医疗拥有大中华区权益的JenaValve Trilogy心脏瓣膜系统ALIGN-AR试验的两年结果发布。ALIGN-AR 2 Years正向结果进一步证实了Trilogy心脏瓣膜系统对治疗严重、有症状的主动脉瓣关闭不全（AR）且高外科风险的患者具有安全性和持续有效性。</p><img src=\"https://static.tigerbbs.com/a0677190bc27cbb2be757ac2a9e9c41d\" tg-width=\"1493\" tg-height=\"1875\"></body></html>","text":"$沛嘉医疗-B(09996)$ 沛嘉医疗拥有大中华区权益的JenaValve Trilogy心脏瓣膜系统ALIGN-AR试验的两年结果发布。ALIGN-AR 2 Years正向结果进一步证实了Trilogy心脏瓣膜系统对治疗严重、有症状的主动脉瓣关闭不全（AR）且高外科风险的患者具有安全性和持续有效性。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/365940418564200","repostId":0,"isVote":1,"tweetType":1,"viewCount":251,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["09996"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":233,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}